PIPE-307
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PIPE-307, covering 2025-10-23 to 2025-10-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis [Phase 2]